Gastro Esophageal Reflux Clinical Trial
Official title:
Healthy Control Esophageal and Gastric Registry and Biorepository
The evaluation of the foregut, the esophagus and stomach, has come a long way over the past two decades, and continues to experience exciting discoveries in the clinical evaluation of foregut physiology. Assessing esophageal peristalsis has relied for the past several decades on High Resolution Manometry (HRM), however it has recently become known that even though HRM is an extremely effective tool, that there are certain subsets of patients in which additional information is required. Additionally, the assessment of esophageal reflux disease has relied on pH impedance for the last two decades. However, this procedure requires a catheter to be passed through a nostril and remain in place for at least 24 hours. Novel techniques, already FDA approved, including EndoFLIP for esophageal peristalsis and mucosal integrity (MI) for reflux disease, have emerged as time-of-endoscopy assessments. Both involve the placement of a balloon through the scope at time of upper endoscopy (standard first line assessment for both dysphagia and reflux symptoms) and are quick and pose little-to-no additional risk or discomfort for patients. However, data regarding normal esophageal parameters are poorly defined for both EndoFLIP and MI. Additionally, EndoFLIP has increasingly been used to assess the pylorus, and scarce data exists there regarding how a tool originally envisioned for esophageal assessment can be used more distally in the GI tract. We will recruit healthy, asymptomatic volunteers to undergo testing with MI and FLIP (esophageal and pyloric). The data obtained will help establish the benchmark from which assessments can be made in patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06025773 -
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
|
Phase 1 | |
Recruiting |
NCT06280664 -
Efficacy Of Hiatal Closure For GERD
|
||
Recruiting |
NCT05359965 -
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
|
N/A | |
Completed |
NCT04202692 -
Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment
|
N/A | |
Active, not recruiting |
NCT03646045 -
Transpyloric Feeding for Prevention of Micro-aspiration
|
||
Recruiting |
NCT06430047 -
Efficacy and Safety of EsoDuo®
|
Phase 4 | |
Completed |
NCT04268719 -
Near Focus NBI-Driven Artificial Intelligence for the Diagnosis of Gastro-Oesophageal Reflux Disease
|
||
Active, not recruiting |
NCT04614974 -
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
|
Phase 1/Phase 2 | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Recruiting |
NCT03868267 -
Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting
|
||
Terminated |
NCT04028466 -
Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features
|
Phase 4 | |
Active, not recruiting |
NCT05371717 -
Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite
|
N/A | |
Recruiting |
NCT05066594 -
Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)
|
||
Completed |
NCT03476265 -
Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility
|
N/A | |
Completed |
NCT03143608 -
GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery
|
N/A | |
Completed |
NCT04436159 -
Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia.
|
N/A | |
Completed |
NCT03258528 -
Effect of Right Lateral Position on Ventilated Preterm Neonates
|
N/A | |
Active, not recruiting |
NCT04500288 -
The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study
|
N/A | |
Completed |
NCT04262648 -
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
|
N/A | |
Recruiting |
NCT04846010 -
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
|
Phase 1/Phase 2 |